ACA vs DY

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

ACA

50.5
AI Score
VS
ACA Wins

DY

48.7
AI Score

Investment Advisor Scores

ACA

51score
Recommendation
HOLD

DY

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACA DY Winner
Revenue 3.97B 1.23B DY
Net Income 206.93M 366.30M ACA
Net Margin 5.2% 29.8% ACA
ROE 10.0% 12.3% ACA
ROA 3.2% 6.9% ACA
Total Assets 6.54B 5.30B DY
Cash 340.08M 432.10M ACA
Current Ratio 2.35 3.12 ACA
Free Cash Flow -60.75M -41.60M ACA

Relative Price Performance (Last 90 Days)

ACA 1M: +0.8% · 3M: +0.8% DY 1M: -8.0% · 3M: -36.6%

Current Technical Phase

ACA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.0 · Price: $146.55

DY

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.5%), weak momentum, RSI 33

RSI (14): 33.0 · Price: $273.18

Fundamentals Snapshot

Metric ACA DY
Market Cap — —
Forward P/E 28.6 19.8
Trailing P/E 32.6 24.6
Revenue (TTM) — —
Revenue Growth 0.0% 0.5%
Gross Margin 0.2% 0.2%
Operating Margin 0.1% 0.1%
EPS 4.48 10.95
Dividend Yield 0.00% —

Frequently Asked Questions

Based on our detailed analysis, ACA is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.